TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
28,107
|
21,629
|
21,131 |
| Financial expenses |
3
|
25
|
45 |
| Earnings before taxes |
-980
|
-1,044
|
150 |
| EBITDA |
-699
|
-737
|
563 |
| Total assets |
29,681
|
26,441
|
23,623 |
| Current assets |
18,159
|
14,932
|
12,684 |
| Current liabilities |
6,743
|
6,753
|
4,070 |
| Equity capital |
16,866
|
16,491
|
15,338 |
| - share capital |
206
|
203
|
189 |
| Employees (average) |
13
|
12
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
56.8%
|
62.4%
|
64.9% |
| Turnover per employee |
2,162
|
1,802
|
1,509 |
| Profit as a percentage of turnover |
-3.5%
|
-4.8%
|
0.7% |
| Return on assets (ROA) |
-3.3%
|
-3.9%
|
0.8% |
| Current ratio |
269.3%
|
221.1%
|
311.6% |
| Return on equity (ROE) |
-5.8%
|
-6.3%
|
1.0% |
| Change turnover |
6,088
|
-1,001
|
-2,640 |
| Change turnover % |
28%
|
-4%
|
-11% |
| Chg. No. of employees |
1
|
-2
|
0 |
| Chg. No. of employees % |
8%
|
-14%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.